 |
 Today's News
 |
IntelGenx, RedHill enter pact to co-develop, commercialise anti-migraine oral film product
(18:00 IST)
|
|
Xcelience, IriSys enter business alliance pact to strengthen regional access to CMC & regulatory expertise
(17:00 IST)
|
|
Study shows combo therapy of telmisartan & amlodipine significantly reduces blood pressure in hypertension patients
(16:00 IST)
|
|
Reckitt Benckiser Pharma receives US FDA nod for Suboxone sublingual film
(15:00 IST)
|
|
Kythera, Bayer dermatology unit Intendis enter licensing, development pact for adipolytic agent ATX-101
(14:00 IST)
|
|
BTG buys marketing rights of CroFab & DigiFab from Nycomed
(13:00 IST)
|
|
Fortis Hospitals launches cancer institute in Mumbai
(12:30 IST)
|
|
Pfizer to acquire FoldRx Pharmaceuticals
(12:00 IST)
|
|
SemBioSys receives US patent for production of apolipoprotein in plants
(11:00 IST)
|
|
Largest atrial fibrillation registry reveals poor AF control & high rates of cardiovascular hospitalization
(10:00 IST)
|
|
Health Canada approves Sativex for treatment of spasticity due to multiple sclerosis
(09:00 IST)
|
|
|
|
 |
| |
|
Today's Top News |
|
Parliamentary Panel expresses anguish over inordinate delay in finalising pharma policy
(08:00 IST)
|
|
Kerala drugs control authorities will conduct further analytical test on Musli Power Xtra products
(08:00 IST)
|
|
Industry needs to enhance knowledge across domains to tap burgeoning opportunity in global arena: Expert
(08:00 IST)
|
|
Health Ministry asks State govts to adopt Clinical Establishment Bill
(08:00 IST)
|
|
Pharmexcil signs MoU with DIA to support SMEs in pharma exports
(08:00 IST)
|
|
IPA, K’taka, KDPMA & NKDMA to organize one-day seminar on GLP on Sept 4, 2010
(08:00 IST)
|
|
 |
| |
|
Yesterday's News |
|
Forest Labs, Gedeon Richter announce phase II study results of cariprazine for bipolar depression |
|
Ranbaxy begins operations at new SA facility, invests US$ 30 million |
|
Nanotherapeutics submits IND application with US FDA for clinical testing of oral drug to treat radiation exposure |
|
Mukul Joshi takes over as secretary, Department of Pharmaceuticals |
|
BioTime to launch seven new embryonic progenitor cell lines on Sept 1, 2010 |
|
Ecron Acunova reappoints Dr Klaus Wiedey as MD & CEO for Europe operations |
|
Athera Biotech, Electra-Box Diagnostica sign agreement for distribution of CVDefine kit. |
|
US FDA extends Eisai's eribulin mesylate NDA review period for 3 months |
|
Healis acknowledges UN resolution on pregnant women exposure to secondhand smoke |
|
Cryo-Save to conduct public awareness on cord blood stem cell |
|
US patent for Marina Biotech's fundamental RNAi delivery |
|
GSK, Valeant Pharma say US FDA extends PDUFA goal date for ezogabine |
|
Sun Pharma subsidiary receives US FDA warning, gets approval for generic Strattera caps |
|
BARDA awards contract to Achaogen to develop antibiotic drugs to treat plague and tularemia infections |
|
Trius Therapeutics begins phase 3 study of oral torezolid phosphate to treat ABSSSI |
|
Lonza acquires viral vaccine & vector manufacturer Vivante GMP Solutions |
|
Health ministry issues notices to Indian doctors took part in Lancet's NDM-1 study |
|
Official tests confirm 'Musli Power Extra' of Kunnath Pharmaceuticals as adulterated |
|
IDMA objects to govt treating MSRs as workmen |
|
Kerala's second drug testing lab to come up at Kakkanad at a cost of Rs 4.8 cr |
|
I-AIM gets Rs7 cr. from DST, Environ Min for Rasayana Research Centre |
